^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in Ringer’s injection, lactated.

^d Preservative free.

^e Injected via Y-site into an administration set running azithromycin.

^f Final concentration after mixing.

^g Tested in both dextrose 5% and sodium chloride 0.9%.

^h Test performed using the Cubicin formulation.

ⁱ Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^j Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^k Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^l Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

^m Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

ⁿ Tested as the premixed infusion solution.

^o Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.